A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma.
Kollmeier AP, Barnathan ES, O'Brien C, Chen B, Xia YK, Zhou B, Loza MJ, Silkoff PE, Ge M, Thurmond RL.
Kollmeier AP, et al. Among authors: chen b.
Ann Allergy Asthma Immunol. 2018 Nov;121(5):568-574. doi: 10.1016/j.anai.2018.08.001. Epub 2018 Aug 11.
Ann Allergy Asthma Immunol. 2018.
PMID: 30102965
Clinical Trial.